Publications & Posters

Researchers developed a preliminary Luminex-based multiplex assay to detect IgG and IgA antibodies against seven human papillomavirus types: HPV-6, 11, 16, 18, 35, 45 and 58. The assay used commercially available L1 proteins and was evaluated using a blinded proficiency panel. The assay demonstrated strong performance for IgG detection, including 100% sensitivity and specificity for […]

September 16, 2026

Researchers developed a dual-marker point-of-care syphilis assay using gold-silver-gold multilayer plasmonic nanoparticles to improve the detection of treponemal and non-treponemal antibodies. Evaluation with 36 clinical serum specimens—including de-identified samples supplied by Boca Biolistics—produced stronger signals than conventional gold nanoparticle reporters and detected low-titer specimens missed by the comparison strips, supporting further development of rapid, instrument-free […]

August 19, 2026

A recent study published in the Journal of Clinical Virology Plus evaluated the analytical and clinical performance of the Siemens Healthineers HIV Antigen/Antibody Combo (CHIV) assay across the Atellica CI, Atellica IM, and ADVIA Centaur XP analyzers. Using more than 3,300 clinical samples, researchers demonstrated greater than 99% agreement between platforms, confirming comparable precision, sensitivity, and reliability for HIV serological testing. The study also showed 100% agreement across HIV seroconversion panels, supporting consistent early HIV detection. Boca Biolistics contributed well-characterized HIV-positive and HIV-negative serum specimens used in the analytical verification phase, highlighting the importance of high-quality biospecimens in diagnostic assay validation and regulatory studies.

June 4, 2026

This study compared phage display and hybridoma technologies for generating antibodies against Zika virus NS1. Phage display-derived antibodies demonstrated greater specificity, while hybridoma-derived antibodies provided greater sensitivity. A combined antibody format achieved a detection limit of 1 ng/mL in spiked human serum and showed no cross-reactivity with dengue-positive serum. Boca Biolistics supplied clinically characterized Zika- […]

March 14, 2026

This study evaluates the GenXplore Q4800, a fully automated open-platform nucleic acid testing system designed for molecular diagnostics. Results demonstrate high sensitivity, reproducibility, and contamination control across multiple applications, including sexually transmitted infections and respiratory virus detection. Clinical validation showed 100% agreement with reference methods, confirming accurate pathogen detection. The system’s open-platform design enables flexible use of third-party reagents, providing a scalable and cost-effective solution for modern diagnostic laboratories.
Chen H, Wu J, Lin H, Chen Y, Cheng Y, Lu C, Fan K, Huang K, Wen C, Yu S, Lin Y, Huang Y, Chi R. 0.

January 21, 2026